[フレーム]

Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

OK
MENU
Back to Top

At IPA, we bring the full spectrum of geriatric mental health to light...

...all issues, all disciplines, all around the world!

Message from the President
Message from the President
IPA's Journal - International Psychogeriatrics (IPG)
IPA's Journal - International Psychogeriatrics (IPG)
IPA Bulletin
IPA Bulletin
IPA Secretariat - Contact Us!
IPA Secretariat - Contact Us!
Membership
Membership
Products and Services
Products and Services
Advocacy and Public Awareness
Advocacy and Public Awareness
Mentorship and AI Task Forces
Mentorship and AI Task Forces

Featured Resources

Can the PROPER intervention reduce psychotropic drug prescription in nursing home residents with dementia? Results of a cluster-randomized controlled trial
Can the PROPER intervention reduce psychotropic drug prescription in nursing home residents with dementia? Results of a cluster-randomized controlled trial

In order to improve the prescription of psychotropic drugs, we developed the PROPER intervention. This intervention has....

Management of agitation in dementia: Good practice or malpractice?
Management of agitation in dementia: Good practice or malpractice?

Management of agitation is challenging in the absence of Food and Drug Administration (FDA)-approved pharmacological options. The first-line approach is non-pharmacological and involves caregiver...

Highlighting the use of anticholinergics and antipsychotics in older adults: awareness and de-prescription
Highlighting the use of anticholinergics and antipsychotics in older adults: awareness and de-prescription

De-prescribing has been promoted to reduce medication-related harm which incorporates principles of dose optimization and reduction or discontinuation of inappropriate medications. Anticholinergic medications and antipsychotics...

Clinical impact of antipsychotic and benzodiazepine reduction: findings from a multicomponent psychotropic reduction program within long-term aged care
Clinical impact of antipsychotic and benzodiazepine reduction: findings from a multicomponent psychotropic reduction program within long-term aged care

Generally, clinical guidelines recommend reserving antipsychotics for cases where the resident may harm themselves or others, or where non-pharmacological...

Acknowledgements

Acadia Pharmaceuticals Axsome Lundbeck Otsuka

AltStyle によって変換されたページ (->オリジナル) /